Search results
The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
Bloomberg via Yahoo Finance· 12 hours ago(Bloomberg) -- There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global...
UPDATE 1-Novo Nordisk owner to invest $200 million in quantum computing startups
Reuters via Yahoo Finance· 13 hours agoNovo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it planned to invest around $200 million in quantum computing startups ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
Investing.com· 1 day agoLilly said it expects significant production increases in the second half of the year for its...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 1 day agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 8 hours agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...
Why Eli Lilly Stock Is Jumping Today
Motley Fool via Yahoo Finance· 1 day agoShares of Eli Lilly and Company (NYSE: LLY) were jumping 6% higher as of 11:03 a.m. ET on Tuesday. The solid gain came after the big drugmaker announced...
These Stocks Moved the Most Today: CVS, AMD, Super Micro, Amazon, Starbucks, Pfizer, Norwegian,...
Barrons.com· 2 hours agoCVS posts a wide miss on first-quarter earnings and cuts guidance, AMD shares fall after the chip...
Missouri Healthnet extends contract with hepatitis C drugmaker
KY3 Springfield· 1 day agoMO Healthnet is progressing toward combating hepatitis C in Missouri. Over half the patients...
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates - Pfizer (NYSE:PFE)
Benzinga· 4 hours agoPFE reported better-than-expected first-quarter financial results. Pfizer reported first-quarter...
Eli Lilly lifts 2024 sales view by $2 billion on weight-loss drug demand By Reuters
Investing.com· 1 day agoSky-rocketing demand for Mounjaro and Zepbound, both chemically known as tirzepatide, has propelled...